<--- Back to Details
First PageDocument Content
Multiple sclerosis / Glatiramer acetate / Lipoatrophy / Medical equipment / Teva Pharmaceutical Industries / Injection / Placebo / Aspirin / Syringe / Medicine / Health / Pharmacology
Date: 2014-07-17 18:08:53
Multiple sclerosis
Glatiramer acetate
Lipoatrophy
Medical equipment
Teva Pharmaceutical Industries
Injection
Placebo
Aspirin
Syringe
Medicine
Health
Pharmacology

Sharps Disposal Plan: Teva

Add to Reading List

Source URL: www.calrecycle.ca.gov

Download Document from Source Website

File Size: 283,68 KB

Share Document on Facebook

Similar Documents

20th NSW Stem Cell Network Workshop - in collaboration with MS Research Australia Stem Cells in Multiple Sclerosis and Neurological Disease

DocID: 1vbZP - View Document

Insights into Type 1 Diabetes and Multiple Sclerosis Pathogenesis from Common Genetic Associations Sandeep K. Singh 1, Aziz A. Chentoufi 2, Jacob L. McCauley 3, Mehmet Tevfik Dorak 4 1Florida

DocID: 1vaUi - View Document

Cigarette Smoking and Incidence of Multiple Sclerosis -- Heman et al): 69 -- Ame...Page 1 of 14 Oxford Journals • ContactUs ......

DocID: 1v0yh - View Document

MULTIPLE SCLEROSIS Clues to its cause URI LEIBOWITZ Department of Neurology, Hadassah University Hospital and Hebrew U+riversity-Hada.ssah Medical School,

DocID: 1uW5T - View Document

CNS Vital Signs Advancing Multiple Sclerosis Care Adding Value to Your Practice by Providing Solutions for Measuring,  Monitoring and Managing Neurocognitive and Behavioral Health… www.CNSVS.com

DocID: 1uFcb - View Document